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Age versus urinary sodium for judging renin, aldosterone, and
catecholamine levels: Studies in normal subjects and patients with
essential hypertension. The relative influence of sodium balance
and age on plasma renin activity (PRA), aldosterone (PA), nor-
epinephrine (NE), and epinephrine (E) levels, and urinary NE or
E measured in an outpatient setting was evaluated in 90 normal
subjects and 79 patients with benign essential hypertension.
Ranges of age (17 to 76 yr) and urinary sodium excretion (U5a)
(51 to 241 mEq/24 hr) were comparable. In normal subjects, su-
pine or upright PRA and supine plasma E correlated (P < 0.05)
inversely and supine plasma PNE or NE excretion correlated
positively with age, but not with UNa; the upright plasma NE
correlated closer with age than it did with UNa. Supine PA corre-
lated with both age and UNa; upright PA did so only with UNa.
Based on significant relationships with either age or UNa, dynam-
ic normal ranges with 95% confidence limits could be estab-
lished. Hypertensive patients exhibited also age-related de-
creases in PRA and PA and increases in NE; PRA and PA did not
correlate with UNa. Consideration of age revealed low or high
PRA in 10 and 7%, respectively; these abnormalities occurred
more commonly with moderate-severe (>160/105 mm Hg) than
with mild hypertension and were associated with parallel varia-
tions in age-adjusted plasma NE. Nevertheless, plasma NE was
within the normal range, except for slightly low upright values in
15% of patients. PA related to age or UNa was increased in 25% of
patients while supine, but it was usually normal in the upright
position. These findings demonstrate that without profound so-
dium depletion, age may be more important than sodium excre-
tion as a frame of reference for judging both renin and norepi-
nephnne measurements; both factors should be considered for
interpretation of PA. On this basis, one fourth of patients with
essential hypertension have mild hyperaldosteronism while
maintaining the supine position. Low renin hypertension is much
less common than previously suggested and may be related to
low adrenergic activity.
Age ou sodium urinaire pour apprécier les concentrations de ré-
nine, d'aldostérone et de cathéchotamine: Etude chez les sujets
normaux et les malades atteints d'hypertension essentielle.
L'influence relative du bilan du sodium et de l'age sur l'activité
refine plasmatique (PRA) et les concentrations plasrnatiques
d'aldostérone (PA), de norépinéphrine (NE) et d'épinéphrine
(E) et de NE ou E urinaires mesurées chez des malades externes
a été évaluée chez 90 sujets normaux et 79 malades atteints
d'hypertension essentielle bénigne. Les intervalles d'âge (17 à76
ans) et de sodium urinaire (Ua) (51 a 241 mEq/24 hr) étaient
comparables. Chez les sujets normaux Ia PRA en position
couchée ou debout et I'E plasmatique en position couchée sont
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inversement correlées (P < 0,05) et PNE plasmatique ou
l'excrétion de NE en position couchée sont correlées positive-
ment avec l'âge mais non avec UNa alors que NE plasmatique
est mieux correlée avec l'age qu'avec UNa. La PA en position
couchée est correlée a Ia fois avec l'age et UNa, Ia PA en posi-
tion debout seulement avec U. Sur Ia base de relations signifi-
catives avec soit l'âge soit UNa des intervalles de valeurs nor-
males avec des limites de confiance de 95% ont Pu être établis.
Les malades hypertendus ont aussi des diminutions de PRA et de
PA et une augmentation de NE en fonction de l'âge; PRA et PA
ne sont pas correlees avec UNa. La prise en consideration de
l'ãge met en evidence des PRA basses ou élevées dans 10 et 7%,
respectivement, des situations; ces anomalies surviennent plus
souvent dans les hypertensions modérées ou sévères (>160/
105 mm Hg) que dans des hypertensions frustes et sont associees
a des variations parallèles de NE plasmatique ajustée en fonc-
tion de l'àge. Les valeurs de NE plasmatique sont cependant
dans l'intervalle normal a l'exception de valeurs en position de-
bout legèrement élevées chez 15% des malades. La PA en fonc-
tion de l'âge ou de UNa est augmentée chez 25% des malades en
position couchée mais elle est habituellement normale en posi-
tion debout. Ces constatations démontrent qu'en l'absence
d'une déplétion importante de sodium l'âge peut être un facteur
plus important que l'excrétion de sodium comme système de
référence pour apprécier les résultats des determinations de ré-
nine et de norépinephnne. Ces deus facteurs doivent être pris en
consideration pour l'interprétation de PA. Sur cette base, un
quart des malades atteints d'hypertension essentielle ont un hy-
peraldostéronisme minime quand us sont maintenus en position
couchée. L'hypertension a rénine basse est beaucoup moms fré-
quente qu'il n'a été suggéré antérieurement et pourrait étre Iiée
a une activité adrenergique faible.
The activity of both the renin-angiotensin-al-
dosterone system and the adrenergic nervous sys-
tem may be influenced by the body sodium-volume
state. Thus, plasma renin, aldosterone, norepineph-
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rine, and epinephrine levels, and catecholamine ex-
cretion rates are all increased in response to sodium
depletion [1—4]. Based on this relationship, it has
become customary to judge blood levels of renin
and aldosterone in relation to a defined sodium in-
take [1, 2, 5] or 24-hour sodium excretion [6]. The
latter frame of reference is being used widely since
it is applicable to an outpatient setting although
fixed dietary prescriptions are usually not. The rela-
tionships between sodium excretion and plasma re-
nm or aldosterone values are hyperbolic and diffi-
cult to define mathematically. Therefore, simplified
descriptive nomograms have been proposed [6] and
used to stratify patients with hypertension into sub-
groups with low, normal, or high levels of these pa-
rameters [6—9]. This approach, however, does not
take into consideration factors other than sodium
which may also influence renin and aldosterone re-
lease. One of these factors is the age of the patient.
In normal man, both plasma renin and aldosterone
levels decrease progressively from the time of birth
to the seventh decade of life [5, 10—13], but norepi-
nephrine in plasma and urine increases with aging
[13—15].
The relative importance of sodium and age as de-
terminants of these endocrine parameters has not
been clearly delineated. Therefore, the present
study was undertaken to comparatively evaluate 24-
hour sodium excretion and age as frames of refer-
ence for judging plasma renin, aldosterone, and nor-
epinephrine levels, and norepinephrine excretion
rates in a population of ambulatory normal subjects.
To test the clinical and pathogenic revelance of
such an analysis, a large outpatient population with
essential hypertension was also examined.
Methods
Ninety healthy normal volunteers (43 females and
47 males, aged 18 to 76 yr) and 79 patients with es-
sential hypertension (34 females and 45 males, aged
19 to 76 yr) of racially homogenious background
(white) were studied. Secondary hypertension was
excluded by the usual tests. Hypertension was al-
ways benign, and no patient had congestive heart
failure or relevant renal functional impairment
(plasma creatinine > 1.3 mg/l00 ml). Antihyper-
tensive drugs were withdrawn at least 2 weeks be-
fore study and replaced by placebo tablets. Based
on blood pressure values obtained during placebo
conditions, the patients with hypertension (diastolic
>140/90 mm Hg) were divided into 44 with mild(160/105 mm Hg and/or mean pressure 123 mm
Hg) and 35 with moderate to severe hypertension
(>160/105 mm Hg). To avoid very high sodium in-
takes, subjects were instructed to ingest a normal
diet but without very salty foods or adding salt to
their food, starting at least 5 days prior to the test.
Alter completion of a 24-hour collection for deter-
mination of sodium (UNa), potassium, creatinine,
norepinephrine (NE), and epinephrine (E) excre-
tions, supine and upright (each for 1 hour) blood
pressure, pulse rate, plasma sodium, potassium,
creatinine, renin activity (PRA), aldosterone (PA),
NE, and E levels were obtained between 8 and 11
A.M., according to our standard procedure [9, 13].
Indwelling i.v. cannulas were inserted at least 30
mm before blood sampling.
Blood pressure was taken with standard cuff and
sphygmomanometer and was registered as the mean
of three recordings (diastolic pressure = dis-
appearance of sounds). Sodium and potassium con-
centrations were determined by flame photometer;
creatinine, by autoanalyzer; PRA [16] and PA [17],
by radioimmunoassay; and NE and E in urine, by
fluorometric [18], and in plasma, by radioenzymatic
methods [19]. All endocrine measurements were
made in duplicate, and the mean value was used.
Mean coefficients of intraassay, interassay and con-
trol plasma variations in 65 to 210 unselected con-
secutive determinations with these methods were:
PRA, 6.5, 7.6, and 12.2%, respectively; PA, 7.5,
15.8, and 21.2%; urinary NE, 12.4, 16.7, and 6.7%;
urinary E, 6.0, 9.1, and 7.6%; plasma NE, 4.2, 10.1,
and 13.5%; plasma E, 4.4, 15.6, and 22.4%. In 9
normal and 31 hypertensive subjects, repeat studies
after 2 to 10 months revealed the following intra-
subject variations: PRA, 31.3%; PA, 33.3%; urinary
NE and E, 27.4 and 35.2%; plasma NE and E, 24.9
and 38.9%.
Results
Mean values in study groups and subgroups
(Table 1). Mean values of the parameters measured
in the present study did not differ significantly be-
tween normal subjects and patients with either mild
or moderate to severe essential hypertension, with
the following exceptions: plasma sodium concentra-
tion in the entire hypertensive patient population or
in the subgroup with moderate to severe hyper-
tension was slightly but significantly lower than it
was in normal subjects, supine PRA was significant-
ly elevated in the subgroup with moderate to severe
hypertension, and supine PA was significantly ele-
vated in all patients and both subgroups.
Relationships in normal subjects (Table 2): With
sodium excretion. UNa ranged from 51 to 237 mEq/
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Table 1. Biochemical and endocrine parameters in normal subjects and patients with essential hypertension (mean SD)
Parameters Normal subjects
Patients with essential hypertension
Mild Moderate All
Age,yr 37 15 43 16 50 11 46 IS
Blood pressure, mm Hg 117/75 10/8 145/93 19/8 177/118 20/12 160/104
Plasma values:
Sodium, mEqiliter 140 2 139 2 138 3 139 0.3Potassium, mEqilirer 4.0 0.3 4.0 0.3 3.9 0.3
Renin activity, nglmllhr 2.6 3.1Supine 1.9 2.7 2.1 1.5 3•3 44a 2.5Upright 4.6 2.7 4.1 2.7 4.6 5.9
Aldosterone, ng/JOO ml 8.8 6.1cSupine 5.3 2.6 7.9 54b 10.6 6.7c 10.6Upright 15.4 9.7 14.8 11.1 16.4 10.3 15.3
Norepinephrine, ng/lOOml 12.8Supine 16.9 9.1 22.7 15.1 17.2 9.1
Upright 34.4 13.6 30.2 17.0 30.2 13.7 30.2
Epinephrine, ng/IOO ml 5.8 6.9Supine 6.2 6.2 6.8 8.9 4.6 2.8 6.9Upright 7.0 5.6 7.8 6.5 7.6 7.9
Urinary values:
Norepinephrine, g/g creatinine 26.6 12.6 27.3 12.0 28.8 11.2 27.53.1 2.9Epinephrine, ag/g creatinine 3.2 3.5 3.4 2.9 2.7 2.9 137 63Sodium, mEqI24 hr 136 46 133 61 143 56 63 26Potassium, mEq/24 hr
Creatine clearance, ml/minlI.73m2
65
86
22
18
65
97
27
32
60
84 27 89 30
a P < 0.025 vs. normal.
P < 0.005 vs. normal.
P <0.001 vs. normal.
hr. With or without inclusion of elderly subjects
(60 yr), there were no significant correlations be-
tween these values and supine or upright PRA, su-
pine plasma NE, NE excretion rate, or supine or
upright plasma E levels. Therefore, statistical defi-
nition of normal ranges with 24-hour UNa as the
frame of reference could not be derived for these
parameters. Weak but significant inverse correla-
tions, however, were found between UNa and up-
right plasma NE or supine or upright PA levels
(Table 2), so that normal ranges with 95% con-
fidence limits could be calculated.
With age. There were significant inverse relation-
ships between age and supine or upright PRA (Fig.
1) or supine PA, and positive relationships between
age and supine or upright plasma NE or NE excre-
tion rates (Table 2). Thus, normal ranges related to
age could be established. The correlation coeffi-
cients for these relationships with age were not in-
creased with multiple regression analysis using UNa
as the second independent variable, except for the
parameters upright plasma NE (r = 0.64; P < 0.001)
and supine PA (r = 0.41; P < 0.005). There was no
significant correlation between age and upright PA
and plasma or urinary E, except for a weak inverse
relationship with supine plasma E (Table 2).
Relationships in hypertensive patients (Table 2):
With urinary sodium or age. UNa ranged from 51 to
241 mEq/24 hr. UNa correlated inversely with up-
right plasma NE, supine plasma E or NE excretion
rate, but not with PRA (Fig. 2) or other measured
parameters (Table 2). In analogy to normal sub-
jects, most endocrine factors in these hypertensive
patients correlated significantly with age.
Based on the mathematically defined normal
ranges, upright PRA related to age was low in eight
(10%) and high in six (7%) patients; abnormalities
were even less common for supine PRA (Fig. 3). In
the subgroup with mild hypertension, the slope for
the renin-age relationship was comparable to that in
normal subjects; and no patient in this subgroup had
markedly high PRA levels. The subgroup with mod-
erate to severe hypertension exhibited a steeper
slope for the renin-age relationship. Thus, five of
the six hyperrenemic and five of the eight patients
with low PRA relative to age belonged to the latter
subgroup (Fig. 3).
Supine PA related to either UNa (Fig. 4) or age
(Fig. 5) was high in 12 (27%) patients; five of them
belonged to the high-renin and seven to the normal
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Table 2. Correlation matrix of the relationships between various endocrinological parameters and urinary sodium or age in normal
subjects and patients with essential hypertension
Parameters
Norm
N
Essential hypertension
al subjects Mild
r N r N
Moderate
r N
All
r
.Plasma renin Relationships with urinary sodium
Supine 99 0.03 38 —0.08 25 —0.16 63 —0.10
Upright 97 0.06 44 —0.02 35 —0.20 79 —0.14
Plasma aldosterone
Supine 80 —0.29" 25 0.01 19 —0.26 44 —0.04
Upright 79 —0.35 28 —0.05 19 —0.20 47 —0.08
Plasma norepinephrine
Supine 44 —0.05 21 —0.27 15 —0.31 36 —0.28
Upright 53 —0.27° 20 —0.33 14 —066" 34 —0.5P
Urinary norepinephrine 58 —0.07 38 29 67 —0.40°
Plasma epinephrine
Supine 41 0.22 20 —0.18 14 —0.57' 34 —0.29°
Upright 43 0.17 20 —0.24 14 —0.42 34 —0.26
Urinaryepinephrine 60 0.25° 38 —0.23 29 —0.06 67 —0.15
Plasma renin Relationships with age
Supine 89 —0.45° 38 —0.50" 25 0.42" 63
Upright 90 —0.53° 44 35 —0.52° 79 —0.50°
Plasma aldosterone
Supine 70 —0.29° 26 —0.28 19 —0.31 45 —0.22
Upright 70 0.04 29 —0.31° 19 —0.35 48 —0.27°
Plasma norepinephrine
Supine 36 0.32a 21 056b 15 0.40 36 0.43"
Upright 45 0.49° 20 0.48" 14 —0.07 34 0.28
Urinary norepinephrine 58 0.42° 38 0.51" 29 —0.09 67 0.34"
Plasma epinephrine
Supine 41 —0.29° 20 0.15 14 0.10 34 0.11
Upright 43 0.01 20 —0.14 14 0.01 34 —0.08
Urinary epinephrine 58 0.22 38 0.09 29 0.10 67 0.05
a P < 0.05.
b P < 0.025.
P < 0.01.
d P < 0.005.
ep <0.001.
renin subgroups. Upright PA related to UNa was
usually normal (Fig. 4). Upright plasma NE related
to UNa (Fig. 6) and supine plasma NE (Fig. 7) or
urinary NE related to age were usually normal, but
upright plasma NE related to age tended to be
slightly low in 15% of patients. The norepinephrine-
age relationships were again comparable in normal
and mildly hypertensive subjects; but there was no
such correlation in moderate to severe hyper-
tension.
Between renin and norepinephrine. There was no
significant correlation between absolute levels of
supine or upright PRA and corresponding plasma or
urinary NE values in either normal (r = 0.03) or
hypertensive subjects (r = 0.17). Considering, how-
ever, the contrasting influence of age on these fac-
tors, their relationship was explored further by a)
dividing the hypertensive patients into three cate-
gories with age-related upright PRA levels below
the 16th, between the 16th and 84th, and above the
84th percentile (see Fig. 3); and b) adjusting NE lev-
els to a reference age of 40 years by means of the
regression equation. Age-adjusted upright plasma
NE values did not differ between normal subjects
(37.6 [± SD] 13.0 ng/100 ml) and the hypertensive
normal- or high-renin categories (30.2 14.8 and
46.8 12.3 ng/100 ml); they were significantly de-
creased in the low-renin category (21.6 13.2 ng/
100 ml; P < 0.0 125) and tended to be higher in the
high than they were in the normal renin category
(P < 0.05). Mean age-related urinary NE was also
lower in the low-renin category (18.5 6.7 Lg/g
creatinine) than it was in the normal- or high-renin
categories (27.2 9.8 and 25.5 8.5 g/g creati-
nine; P < 0.005 and < 0.05, respectively) or normal
subjects (24.3 11.1 g/g creatinine; P < 0.05),
without significant differences between the three
latter groups.
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Fig. 3. Supine and upright plasma renin levels related to age in
patients with essential hypertension (BP f). Theshaded areas
and closed regression lines represent the ranges with 95% con-
fid'ñce limits and regression lines obtained from normal sub-
jects.
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Fig. 1. Relationship between supine or upright plasma renin lev-
els and age in normal subjects. The lines represent the regression
line and the 95% confidence limits.
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50 100 200 250 was also higher than that in the low- or normal-renin
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Using the absolute levels, supine or upright PA
correlated significantly with corresponding PRA
levels in both normal (r = 0.42, P < 0.001; r 0.27,
Urinary sodium excretion, mEq/24 hr
Fig. 2. Relationship between upright plasma renin activity and
24-hr urinary sodium excretion in normal subjects and patients
with essential hypertension.
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Fig. S. Supine plasma aldosterone levels related to age in pa-
tients with essential hypertension (BP 1). Theshaded area with
regression line represents the range with 95% confidence limits
obtained from normal subjects.
Fig. 4. Supine and upright plasma aldosterone levels related to
24-hr sodium excretion in patients with essential hypertension
(BP 1). The shaded areas with regression lines represent the
ranges with 95% confidence limits obtained from normal sub-
jects.
P < 0.05) and hypertensive subjects (r = 0.43 and
0.53,1? < 0.001).
Discussion
lowed the policy of asking the patients to ingest a
diet avoiding the very salt-rich foods and added
salt. Using this instruction, our 90 normal control
subjects and 79 patients with essential hypertension
had comparable UNa excretions (136 vs. 137 mEq/24
hr) ranging from 51 to 241 mEq/24 hr. Spontaneous
reduction of salt intake below 3 g/day may be rare.
Under these conditions, age was more important
than was sodium excretion as a frame of reference
for judging both renin and norepinephrine measure-
ments. In fact, supine and upright PRA correlated
The dietary conditions of this study are well ac-
cepted and used widely in the screening evaluation
of PRA, PA, or catecholamine levels, or urinary
catecholamine excretion rates in patients with hy-
pertension. Since admission to a hospital for all
such determinations would be prohibitive finan-
cially, and since fixed dietary intakes or special ma-
neuvers such as profound sodium restriction are not
easily applied in an outpatient setting, we have fol-
Urinary sodium excretion, mEq/24 hr
Fig. 6. Upright plasma norepinephrine levels related to 24-hr so-
dium excretion in patients with essential hypertension (BP 1).
The shaded area and closed regression line represent the range
with 95% confidence limits and regression line obtained from
normal subjects.
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inversely and plasma or urinary NE correlated (P <
0.05) positively with age, but not with UNa; and the
positive relationship of upright plasma NE with age
was closer than was its inverse correlation with
UNa. Plasma or urinary [131 E levels did not cone-
late consistently with either frame of reference. It
follows that normal ranges relative to UNa could be
defined mathematically only for upright plasma NE;
in contrast, such dynamic ranges relative to age
could be established for PRA or plasma NE in both
body positions as well as it could for NE excretion
rates. These findings reduce the value of subjecting
outpatients scheduled for PRA or plasma cate-
cholamine determinations routinely to a 24-hr urine
collection for measurement of sodium, a procedure
clearly more complicated than that which uses sim-
ply the patients age as reference.
The lack of a renin-sodium correlation in our nor-
mal population does not militate against the exis-
tence of a hyperbolic relationship when values ob-
tained during more profound sodium restriction are
included [6—9, 20]. The dynamic part of the arbi-
trary nomograms based on this interrelation, how-
ever, has been limited to low sodium intakes; in
contrast, the effect of variations in body sodium
with UNa between 50 and 300 mEq/24 hr had only a
minor modulating influence on PRA [6—9, 13, 20,
21]. Moreover, the statistical variation of such re-
nin/UNa nomograms was reduced by incorporating
many paired or tripled observations for the same
subjects studied under several dietary conditions [6,
91. Therefore , these nomograms may have underes-
timated individual variation, they had no mathemat-
ical basis, and they did not consider age as a factor.
The latter would appear mandatory at any level of
sodium balance, since stimulated PRA values that
were measured following low sodium diet or potent
diuretics [22, 23] decreased also significantly with
aging [5, 11, 20, 21].
Mild increases in blood pressure with aging could
contribute to renin suppression [9, 24]. The contri-
bution of the latter factor itself to low renin levels in
a normal elderly man, however, may be minimal
[5, 13, 21].
Compared to PRA, PA seemed to be more depen-
dent on variations in sodium intake. Thus, PA con-
centrations in both body positions correlated in-
versely with UNa, which allowed us to delineate
mathematically defined normal ranges; but such a
relationship with age was noted only for supine PA.
Others noted also that a more precise relationship
exists between UNa and aldosterone secretion rates
L71PJ
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--- MUd BR t 21 0.56 <025
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Fig. 7. Supine and upright plasma norepinephrine levels related to age in patients with
essential hypertension (BP U The shaded area and closed regression lines represent the
ranges with 95% confidence limits and regression lines obtained from normal subjects.
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than that which exists between UNa and serum renin
levels [25]. The greater sensitivity of PA to dietary
variations may be related to a modulating influence
of sodium on adrenocortical responsiveness to an-
gioten sin or other factors [26]. The absence of a sig-
nificant inverse relationship between upright PA
and age is due to marked postural aldosterone stim-
ulation in some elderly subjects, a finding that is
possibly secondary to orthostatic decreases in
blood pressure occurring preferentially in this age-
group and eliciting a renin-independent stimulus
[13, 271. It appears that for judging aldosterone
measurements both sodium excretion and age
should deserve consideration.
Regarding PRA in essential hypertension, three
conclusions based on our observations appear justi-
fied. First, considering age as a factor, we found the
incidence of true low renin essential hypertension
to be 10%. This is substantially lower than previous
estimates have suggested [6, 9, 22, 23, 28—321. A di-
rect comparison between the present data and the
many higher estimates of low renin levels in which
age was not considered [6, 22, 23, 28—32] is not pos-
sible. Some investigators found an age-related de-
crease in PRA in essential hypertension, but not in
control subjects [23, 30, 33]; the number of older
normal subjects included, however, was small, and
the renin methodology in two studies differed from
ours since a bioassay [30] or a procedure which
does not discriminate between active renin and in-
active renin precursor [34] was used. Moreover,
that PRA decreases with age not only in hyperten-
sive but also in normotensive subjects is now well-
documented [5, 10, 11, 13, 21, 321. There is also a
tendency for low PRA in black subjects [16, 22, 23].
Taking both age and race into account, the in-
cidence of low renin essential hypertension in a ra-
cially mixed study group was recently calculated to
be 9% [35]. This and the finding of a similar distribu-
tion of PRA in 50-year-old normotensive and hyper-
tensive men [36] support our own low estimate in an
entirely white population. It is suggested that pos-
sible diagnostic, therapeutic, and prognostic impli-
cations of low and high renin levels in hypertension
[371 should be reexamined excluding those patients
with physiological variations due to their age.
A second conclusion on renin concerns dif-
ferences related to severity of hypertension. Distri-
bution of individual values and slopes for the renin-
age relationship were comparable in our normal and
mildly hypertensive subjects, but this slope was
steeper in those with moderate to severe hyper-
tension. Moreover, five of six patients with high
PRA and six of eight with low PRA belonged to the
latter subgroup. The greater prevalence of hyper-
reninemia in younger and of hyporeninemia in older
or more severely hypertensive patients is in accord-
ance with previous data [6, 9, 11, 21, 23, 24, 301.
The almost complete absence of high PRA values in
our patients with mild hypertension, however, con-
trasts with some other reports [38]. Patient selec-
tion and the lack of age-related normal ranges may
be reasons for these differences.
As a third conclusion on renin in essential hyper-
tension, the association of age-related low PRA
with low plasma or urinary NE levels in our patients
supports a role for decreased adrenergic nervous
activity in the pathogenesis of the low-renin state
[9, 29, 38, 391. In contrast to previous studies [38—
40], a relationship between PRA and plasma NE,
however, could not be delineated simply by com-
paring their absolute levels (r = 0.17); the lack of
such correlation in this and other investigations [20]
is expected in view of the contrasting slopes for the
relationships between these parameters and age.
Furthermore, even when considering age, our data
do not confirm significant hypercatecholamine in
high-renin essential hypertension [39, 401. It is pos-
sible that high-renin levels may often be more de-
pendent on hypovolemia than on elevated adrener-
gic activity [91.
The significant (P < 0.005) increase in mean su-
pine PA levels in our hypertensive population, re-
gardless of severity of hypertension or renin sub-
group, complements previous observation by Genest
et al [35]. Individual supine PA levels related to either
urinary sodium or age were above the upper limit of
normal in 27% of our patients, compared to high
values in one third of Genest's cases [ii, 35]. Al-
though age-corrected PA values were highest in our
high-renin patients, mild hyperaldosteronism was
also commonly associated with normal PRA. On
the other hand, PA levels measured in the upright
position were comparable between our normal and
hypertensive subjects. This discrepancy between
high supine and normal upright values probably re-
flects diminished postural aldosterone responsive-
ness [11,411 secondary to low PRA [41, 42] in some
patients with essential hypertension. Previous stud-
ies of 24-hour aldosterone excretion or secretion
rates [6, 25, 43, 44] may have been less sensitive in
detecting such mild abnormalities in circulating a!-
dosterone. Nevertheless, some authors reported in-
creased urinary aldosterone levels in essential hy-
pertension [35], especially during very high sodium
intake [41, 45]. The mechanisms contributing to a!-
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terated metabolism of aldosterone, and possibly al-
so other mineralocorticoids, in essential hyper-
tension are only partly understood and may be re-
lated to decreased hepatic clearance, and possibly
also changes in adrenal production [35].
The exact role of the sympathetic nervous system
in essential hypertension is still unclear. Whatever
frame of reference could be used for judging plasma
or urinary NE, these values were usually normal,
except for somewhat low upright circulating NE rel-
ative to age in 15% of our patients. Other studies
delineating a physiological age-related increase in
urinary [9, 13] or plasma NE [14, 46, 47] revealed
also no evidence for abnormally high levels in es-
sential hypertension. Nevertheless, this has re-
mained a controversial issue [38, 40], although
some reports of high NE values cannot be inter-
preted since age was not considered as a factor [48,
49]. Plasma and urinary E levels which may provide
information on the adrenomedullary portion of the
sympathetic system were normal in our hyperten-
sive patients and in those of others [38, 461. This
contrasts with a recent report of increased plasma E
in such patients [47]; using the same radioenzymatic
method [19], we have no explanation for this dis-
crepancy. Although it remains difficult to in-
criminate increased adrenergic activity as an impor-
tant factor, recent data from this laboratory suggest
that an exaggerated pressor sensitivity to normal
blood levels of norepinephrine may play a patho-
genic role in the maintenance of essential hyper-
tension [15].
These findings illustrate the relative importance
and practical applications of urinary sodium and age
as alternative frames of reference for judging sever-
al endocrine pressor substances. Since age may be
often more important, consideration of this factor
for definition of normal ranges appears mandatory
for any laboratory performing such determinations.
This may facilitate accurate interpretation of renin,
catecholamine, and aldosterone measurements in
patients with hypertension or other disorders.
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